InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: None

Wednesday, 03/08/2023 10:18:15 AM

Wednesday, March 08, 2023 10:18:15 AM

Post# of 425648
Don't count out Merck,

Merck's cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2:

https://www.fiercebiotech.com/biotech/mercks-cardiovascular-future-takes-shape-sotatercept-overachieves-and-oral-pcsk9-passes
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News